A Personalized, Dynamic Physical Activity Intervention Is Feasible and Improves Energetic Capacity, Energy Expenditure, and Quality of Life in Breast Cancer Survivors

by Tarah J. Ballinger, Sandra K. Althouse, Timothy P. Olsen, Kathy D. Miller, Jeffrey S. Sledge
Published 2021-04-01

Thermoacoustic Molecular Imaging of Small Animals

by Robert A. Kruger, William L. Kiser, Daniel R. Reinecke, Gabe A. Kruger, Kathy D. Miller
Published 2003-04-01

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

by Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, Dumitru Brinza, Charles Scafe, Kathy D. Miller, Milan Radovich
Published 2017-07-01

Comparison of Computational Algorithms for the Classification of Liver Cancer using SELDI Mass Spectrometry: A Case Study

by Robert J Hickey, Kathy D. Miller, George W. Sledge, C. Max Schmidt, Lacey E Dobrolecki, Changyu Shen, Timothy E Breen
Published 2007-01-01

Comparison of Computational Algorithms for the Classification of Liver Cancer using SELDI Mass Spectrometry: A Case Study

by Changyu Shen Ph.D., Timothy E Breen, Lacey E Dobrolecki, C. Max Schmidt, George W. Sledge, Kathy D. Miller, Robert J Hickey
Published 2007-01-01

Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells

by Nicholas Pulliam, Jessica Tang, Weini Wang, Fang Fang, Riddhi Sood, Heather M. O’Hagan, Kathy D. Miller, Robert Clarke, Kenneth P. Nephew
Published 2019-01-01

Inflammatory breast cancer appearance at presentation is associated with overall survival

by Wintana Balema, Diane Liu, Yu Shen, Randa El‐Zein, Bisrat G. Debeb, Megumi Kai, Beth Overmoyer, Kathy D. Miller, Huong T. Le‐Petross, Naoto T. Ueno, Wendy A. Woodward
Published 2021-09-01

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

by Maitri Kalra, Yan Tong, David R. Jones, Tom Walsh, Michael A. Danso, Cynthia X. Ma, Paula Silverman, Mary-Claire King, Sunil S. Badve, Susan M. Perkins, Kathy D. Miller
Published 2021-03-01

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

by Bradley A. Hancock, Yu-Hsiang Chen, Jeffrey P. Solzak, Mufti N. Ahmad, David C. Wedge, Dumitru Brinza, Charles Scafe, James Veitch, Rajesh Gottimukkala, Walt Short, Rutuja V. Atale, Mircea Ivan, Sunil S. Badve, Bryan P. Schneider, Xiongbin Lu, Kathy D. Miller, Milan Radovich
Published 2019-08-01

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

by Jennifer R. Diamond, S. G. Eckhardt, Todd M. Pitts, Adrie van Bokhoven, Dara Aisner, Daniel L. Gustafson, Anna Capasso, Sharon Sams, Peter Kabos, Kathryn Zolman, Tiffany Colvin, Anthony D. Elias, Anna M. Storniolo, Bryan P. Schneider, Dexiang Gao, John J. Tentler, Virginia F. Borges, Kathy D. Miller
Published 2018-08-01

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.

by Olga Kim, Eun Young Park, David L Klinkebiel, Svetlana D Pack, Yong-Hyun Shin, Zied Abdullaev, Robert E Emerson, Donna M Coffey, Sun Young Kwon, Chad J Creighton, Sanghoon Kwon, Edmund C Chang, Theodore Chiang, Alexander N Yatsenko, Jeremy Chien, Dong-Joo Cheon, Yang Yang-Hartwich, Harikrishna Nakshatri, Kenneth P Nephew, Richard R Behringer, Facundo M Fernández, Chi-Heum Cho, Barbara Vanderhyden, Ronny Drapkin, Robert C Bast, Kathy D Miller, Adam R Karpf, Jaeyeon Kim
Published 2020-06-01